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THE EFFECT OF SELECTED ADJUVANTS ON THE IN VITRO
PERCUTANEOUS PENETRATION OF BENZOCAINE
Abstract of Dissertation
This research project was designed to test whether the
in vitro percutaneous penetration of benzocaine through
human cadaver skin could be enhanced by dimethyl sulfoxide
(DMSO), urea, polyoxyethylene (20) isohexadecyl ether and
1-dodecylazacycloheptan-2-one (Azone) in propylene glycol/
:~------~w-a-rer-~.t-s-'E€-m-s.
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propylene glycol/water systems was investigated. The
adjuvant effects were studied in a 60/40 (V/V) propylene
glycol/water co-solvent system.
The well known drug penetration enhancer dimethyl
sulfoxide did not enhance the penetration of benzocaine at
any concentration level of DMSO under the conditions of the
experiment. This lack of enhancement effect was probably due
to increased solubility of benzocaine in the DMSO/water system
and a consequent decrease in the partitioning of drug into
the skin. Urea enhanced benzocaine penetration initially but
no significant steady-state penetration enhancement was
noted. Polyoxyethylene (20) isohexadecyl ether appeared to
retard rather than enhance the percutaneous penetration of
benzocaine at concentrations below and around the critical
micelle concentration. Azone showed concentration
dependence for its enhancement effect on penetration of
benzocaine. With 1% V/V Azone, the initial benzocaine
penetration rate was higher compared to the other Azone
concentrations. On the basis of comparative analysis of the
steady-state rates, 5% V/V Azone was observed to be the
most effective penetration enhancer for benzocaine. Azone
also showed additive enhancement properties with increasing
percentages of propylene glycol.
The results of this investigation emphasize the
importance of in vitro skin penetration studies prior to
clinical evaluation. The results also underscore the
importance of a proper experimental design that will
minimize variables during the study in order to properly
identify cause and effect relationships.
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INTRODUCTION
The study of medicaments applied topically has gained
renewed interest in recent years. The skin is one of the
largest organs in the body and the most readily accessible
for application of drugs. However of all the tissues in the
body, the skin surface is one of the least permeable. This
impermeability is related to two factors: the absence of
highly efficient specialized transport systems and the
unique structure of the cells of the stratum corneum (1).
In humans, the skin serves as a protective barrier against
penetration of a variety of substances. The challenge of
overcoming this barrier to promote effective drug delivery
for local and systemic effects has been the subject of
considerable research in both the pharmaceutical and
dermatological fields

(2).

Local anesthetics are widely used in a variety of OTC
products intended for relief of itch and pain -particularly when associated with thermal burns and
sunburn. Since both itch and pain are subserved by the same
network of cutaneous nerves, increasing the intensity of a
stimulus converts the itching sensation to one of pricking
or burning. Increasing the intensity still more induces
true pain (3). One of the most widely used local
anesthetics in OTC burn and sunburn products is benzocaine
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(ethyl aminobenzoate).

It is used at concentrations ranging

from 5 to 20% in a variety of dosage forms such as sprays,
ointments, lotions, creams and foams (3).
Many studies have been done on the action of local
anesthetics on intact, abraded and burned skin, and on
subcutaneous tissue. However in many of these studies, the
assessment of anesthetics efficacy has been based largely
upon subjective clinical impressions (4,5). It has been
reported by Campbell and Adriani (6), that local
anesthetics in general are not absorbed from the intact
skin, but pass into the blood only if the skin is abraded
or burned. This lack of efficacy of many OTC products in
the relief of pain and itch has also been corrorborated by
other in vivo studies of local anesthetics on intact and
sunburned skin (3). There is a noticeable difference in
absorption when local anesthetics are topically applied to
skin and to mucous membrane. Most explanation have stressed
the

histological differences of these two types of

epithelial coverings; but Adriani and Dalili (7) credit
Herman Rein with demonstrating the presence of an
electrostatic barrier effect in the skin, showing that
isolated human skin behaved physiologically as a negatively
charged membrane of single cell thickness. He postulated
that electrostatic charges opposed the penetration of both
anions and cations. It is possible that salts of local
anesthetic agents do not penetrate this layer because they
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are ionized.
The stratum corneum is being constantly regenerated
and has a turnover period of about two weeks. The process
of regeneration begins with a high level of mitotic
activity in the basal layer of the epidermis followed by
the complex process of maturation and migration towards the

and undergo intracellular transformation. The end result is
the dense, keratin-filled and metabolically
--------

inactiy~
•

~···--~-·>·~---~··---~·••"••-"r'~·~·---0..-.-----

layer

of cells. The three-dimensional protein matrix which fills
the intracellular space contains at least two
distinguishable forms of keratin: alpha-keratin, which is
formed or woven into highly ordered filaments and
constitutes about 70% of the intracellular content, and
beta-keratin, which is amorphous or "noncrystalline" and
approximates 10% of the total content. The residual 20% of
the intracellular content is lipid,

including cholesterol,

fatty acids, and triglycerides. The intracellular contents
are about 85% of the total stratum corneum on a dry weight
basis. In its normal state the stratum corneum contains
about 15% water (1). The stratum corneum or the "cornified"
layer is a thin, ultradense polyphasic epidermal covering
made from dehydrated, highly filamented dead cells which
are fused into tight columnar arrangement held together
primarily by tonofibrils and a somewhat indistinguishable
substance. It has been estimated that stratum corneum
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contains ten times the fibrous material in one-tenth the
space as that of the viable epidermis. This forms the
effective barrier of the skin. This composition of stratum
corneum serves to explain the more recent view that the
skin is composed of a complex number of barriers of varying
degrees of penetrability.
Each penetrant may encounter a different type of
barrier, and the degree of penetration is subject to the
chemical and physical properties and the interaction of the
drug with the tissues it attempts to traverse (7). The
stratum corneum, acts a passive diffusion medium, but one
which displays considerable diffusional resistance. Since
the mechanism of penetration through the stratum corneum is
a diffusive process,

Fick's law is generally applied to

describe the process of skin penetration. In general the
viable epidermis and dermis are relatively permeable to
most substances. The stratum corneum is interspersed with
hair follicles and its associated pilosebaceous glands (the
eccrine and apocrine glands). The surface openings of these
structures may provide an effective pathway for penetration
of benzocaine, but their relative importance is doubtful
since hair follicles and pilosebaceous glands occupy
respectively only 1/1,000 and 1/10,000 of the total surface
of skin.
The skin also possesses an adsorptive capacity which
offers a degree of protection against penetration by
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retarding inward migration rather than augmenting
penetration. This type of effect has not been documented
with respect to benzocaine.
The stratum corneum effectively acts as a 'barrier' to
the percutaneous penetration of benzocaine and thus
accounts for the reported lack of efficacy of many OTC
products. Relatively poor penetrability of benzocaine
accounts for the use of excessive high concentrations of
the drug in commercial products. The only product rated as
'effective' contains 20% of benzocaine and yet exhibits a
relatively slow onset of action (3). Enhancement of rate of
penetration of benzocaine topically could lower the
concentration requirement for efficacy while providing a
more immediate relief of pain. Incorporation of suitable
adjuvants in the formulation could help to achieve this
goal.
Many substances when applied to the skin can alter the
permeability properties of the stratum corneum. Of major
interest are those substances that have a mild or
reversible effect on the skin tissue.
Polar solvents, such as dimethylsulfoxide (DMSO) and
dimethylformamide (DMFA), have been shown by many
investigators to be effective vehicles for increasing skin
penetration (9-13). Brechner et

~·

(10)

reported that

tetracaine base dissolved in DMSO penetrated the skin
readily to produce local anesthesia. In vivo anesthesia was
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obtained with concentration of tetracaine from 5 to 30%.
However, Kligman (11) reported a lack of anesthesia in
experiments with the hydrochloride salts of lidocaine and
procaine dissolved in 10 - 90% DMSO. This lack of efficacy
was explained on the basis of low concentrations of the
drugs used and the use of the ionized salt form of the
rugs. In many o

er in vivo and in

v~ro

experiments,

D~~u

has been shown to increase the penetration of water and a
variety of drugs (12,13). This increased diffusivity of the
stratum corneum may be due to the hygroscopic nature of the
solvent (increasing the hydration of the tissue) or
ultrastructural modification of the stratum corneum due to
extraction of soluble components. DMSO does not act as a
'carrier' nor is the increased permeability due simply to a
more favorable partition coefficient for the particular
solute. It has been reported that the effects of DMSO are
to a substantial degree reversible in that the permeability
of tissue is largely restored after the DMSO is removed.
But this point is still in dispute (9,11).
Azone (1-dodecylazacycloheptan-2-one) has recently
received considerable interest as a penetration enhancer.
Stoughton (14) reported that Azone enhances the in vivo
penetration of glucocorticoids, griseofulvin and anthracene
in humans. In a study with hairless mouse skin, Azone was
shown to increase the total flux of ARA-A, an anti-viral
agent, by 20 fold as compared to a formulation using neat
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DMSO (15). Azone has been promoted to enhance penetration
of active substances without producing toxicity, altering
sensitivity or inducing other systemic or local side
effects. The precise mechanism is unknown, but it has been
postulated that Azone alters the lipid and protein
structures of the stratum corneum allowing permeation of
act 1 ve substances in to tne der mi---s.-Radi_-o-a-c-t±ve-stu-d-i-e-s-hav-e·----shown that Azone is bound in the epidermis and corium and
that relatively little is released from the skin (14,16).
It has been reported by various authors (17-19) that
the interaction between surfactant molecules and membrane
components (phospholipids, proteins and water) could lead
to changes in structure and consequently in membrane
permeability. Experiments with rabbit skin have
demonstrated that surfactants can change the content,
composition, and biosynthesis rate of epidermal
phospholipid. Since phospholipids are a major component of
biological membranes, these changes probably indicate
changes in epidermal membrane structure. It is believed
that membrane lipids constitute a barrier to water
diffusion and that the proportions of individual membrane
lipids or their total amount can influence water and ion
transport through these membrane. The effect of surfactants
on the percutaneous absorption of naproxen and benzocaine
across animal and human skin have been reported (20,21).
These results show that, in general, nonionic surfactants
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retard the percutaneous penetration of drugs. This decrease
in penetration could be due to micelle formation thus
affecting the concentration of 'free' drug in the solution.
Urea has attracted interest because of its ability to
moisturize the skin and also its capacity to act as mild
keratolytic (22). Urea has been shown to increase the
percutaneous pene ra ion of

certarn--toyrca~-ant~

inflammatory steroids. Besides the hydrating action on the
stratum corneum, urea has also been used as a solubilizer
for various drugs (23). The effect of urea on solubility is
due to its effect on water structure and hydrophobic
bonding -- thus 'breaking up' water clusters surrounding
nonpolar molecules and increasing the entropy of the system
( 2 3) •

It has been shown by various authors that penetration
of drug molecules can be enhanced by increasing the
hydration of the skin (24,25). Both occlusion and the use
of humectants have been used in attempting to accomplish
this goal. Compounds having humectant properties are, for
example, propylene glycol and di-isopropyl sebacate.
Propylene glycol has shown promising results as a vehicle
for topical delivery when used as a co-solvent with water to
produce saturated solutions of the active ingredient. This
would maximize the thermodynamic activity of the penetrant.
Selection of an appropriate propylene glycol/water mixture
with optimal solubility and partitioning profile could

9

provide a solvent system to facilitate topical penetration
of benzocaine.
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Scope of the Present Study
Incorporation of proper penetration enhancers in
appropriate amounts could point the way to clinically
successful formulations of topical products with an
immediate effect on the relief of itch and pain. In view of
this lucrative goal, this research project was designed to
aocu men t wne t:h:er vrv.rso,-Ar i as o i ve

2-o-o ,

urea,

an--a-A-z-o-n-e-rn.--:,-----~

propylene glycol/water system could enhance the
percutaneous penetration of benzocaine through human
cadaver skin.
Propylene glycol was used as a co-solvent with water
to increase the solubility of benzocaine and also for its
possible penetration enhancement properties. Since DMSO has
been reported to overcome the barrier properties of the
stratum corneum with respect to other drugs, similar
effects were expected with respect to benzocaine.
A mixture of 60/40 (V/V) propylene glycol/water was
chosen as the solvent system for evaluating the effects of
selected adjuvants. The effects on both benzocaine
solubility and percutaneous penetration were investigated.

11

EXPERIMENTAL
All chemicals were used as received from the
manufacturers and their respective lot numbers were logged.
The solubility of the drug in a series of propylene
glycol/water mixtures was determined. The partition
coefficient of benzocaine in the two phase isopropyl
myristate
Guided by the results of solubility and partition
coefficient determinations, an optimum composition of a
propylene glycol/water system was chosen for the in vitro
skin penetration studies. The effect of selected adjuvants
on skin penetration of benzocaine was examined using this
vehicle.
Sol ubi li ty Studies.
The solubility of benzocaine 1 was determined in a
series of propylene glycol2-water3 mixtures (0% to 100% in
20% increments) at 25 + 0.5°. An excess of benzocaine
was weighed and added to 25 ml of propylene glycol/water
mixture in 50-ml Erlenmeyer flasks containing a Teflon

1. 'Baker' Grade, Lot. 847340, J.T. Baker Chemical Co.,

Phillipsburg NJ
2.

U.S.P. Grade, Lot. 9011402/727341, 8395054/727341
9124283/909349, J.T. Baker Chemical Co.,
Phillipsburg NJ

3.

Double distilled water, Univ. of the Pacific,
Stockton CA
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coated magnetic stirring bar and stoppered with a ground
glass stopper. The solution was then stirred magnetically 4
for a period of 48 hours. Each determination was done in
triplicate and the experiment conducted in a constant
temperature room. Prior to sampling, the stirring was
stopped and the excess drug was allowed to settle. An
aliquot of the superna

was

Cake~-arrcl-:E-i-1-t-e-r-ed-w-i-t-h---------

0.22u filter 5 using a syringe with a Swinnex adapter. The
first five ml of the filtrate was discarded to avoid any
error due to the possible saturation and adsorption to the
filter. After appropiate dilution, the concentration was
determined spectrophotometrically.
Assay Methods
Analysis of benzocaine was done on a spectophotometer 6
with a micro flow-through attachment. This allowed for
small sample size and rapid sampling. The absorbance was
recorded at 252nm (26). Beer•s Law was obeyed throughout
the concentration range studied (1.6 to 16.02 mcg/ml). A
standard curve was prepared for each of the propylene
glycol/water mixtures (Appendix A-F). From these curves,
the saturation solubility of benzocaine in each of the
systems was calculated.
4.

Vanlab DYLA-DUAL, V.W.R., San Francisco CA

5.

Swinnex-25, Millipore Filter Corp., Bedford MA

6.

Spectronic 710, Bausch and Lomb, Rochester, NY
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Partition Coefficient
Equal volumes (100 ml) of isopropyl myristate 7 and
different propylene glycol/water systems were allowed to
equilibrate with respect to each other by stirring for 24
hours. After the stirring was stopped, the two phases were
separated by means of a separatory funnel. Excess
benzocaine was added to 25 ml of each of the propylene
glycol/water fractions, stirred for 48 hours and filtered
by means of millipore filter. Three ml of the saturated
solution of benzocaine in propylene glycol/water system was
then agitated for 4 days with 3 ml of the respective
propylene glycol/water saturated isopropyl myristate
solution in stoppered test tubes. The phases were separated
by means of centrifugation and the propylene glycol/water
phase was analyzed for loss of benzocaine to the isopropyl
myristate. The partition coefficient value for each of the
propylene glycol/water systems was then calculated as the
ratio of benzocaine concentration in isopropyl myristate to
that of propylene glycol/water.

7.

Ruger Chemical Co. Inc.,

Irvington NJ
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In Vitro Penetration Studies
It has been reported by various authors (27) that
there is great variability in penetration characteristics
between human skin and animal skin. In vitro penetration
studies done on excised human skin should provide a more
valid representation of

~ ~

humans than the use of an1ma

topical bioavailability in

models:-Ttre~re~fur~e-a~btlo~m-i~n-al:---------

samples of human cadaver skin were used in all penetration
studies.
Preparation of Skin:

Abdominal skin samples obtained

from autopsy were used as received. The skin sample was
excised and placed in a plastic bag and stored in a freezer
for periods up to but not exceeding three months. This
method of storage has been reported not to damage the
intergrity of the skin (28). Before the experiment the skin
was removed from the freezer and allowed to thaw gradually
at room temperature. When the sample was pliable, it was
placed epidermal side down on a dissecting board. All
connective and fatty tissues were removed by means of a
scalpel. Most of the skin samples from a single donor were
able to provide up to 10 - 12 cut pieces for use in the
study.
Skin Cell: The skin cell consists of two parts. The
bottom part is a glass chamber with a sampling port and is
enclosed by a water jacket which allows for circulation of
water at desired temperature. A Teflon-coated magnetic stir

~-
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bar was placed at the bottom of the chamber to ensure
homogeneity in the chamber. The skin sample was placed in
position on a 0-ring between the two ball joints of the top
and bottom chambers, using a pinch type, ground-glass joint
clamp. This exposed an effective diffusion area of 2.01
cm 2 • The top chamber was covered with parafilm during
penetration studies to provide occlusion. Normal saline was
injected into the lower chamber by means of a syringe and
tubing 8 • Air bubbles that might be trapped on the dermal
side of the skin were removed by tilting the skin cell and
allowing them to escape via the sampling port. The cell was
then mounted on top of a magnetic stirrer by means of a
clamp. The temperature of the normal saline in the bottom
chamber was maintained at 37+0.5° by circulating water
from a constant temperature water bath 9 with a circulator
pump. The skin sample was allowed to equilibrate in this
condition for 24 hours. Before any formulation was applied
to the skin, the saline in the bottom chamber was removed
and replaced with fresh saline.
All experiments were carried out for at least 24
hours. Samples were withdrawn at appropriate time intervals
8.

Norton Corp., Akron OH

9.

Haake Model-FE, V.W.R.,

San Francisco CA
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and analyzed spectrophotometrically. All formulations were
studied in duplicate. The data obtained from each run were
computed and analyzed statistically by means of a
computer10. The average amount penetrated per unit area per
unit time was then plotted against time and the resultant
steady state penetration rate was calculated.

10.

Osborne 1, Osborne Computer Corp., Hayward, CA
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RESULTS AND DISCUSSION
The factors which govern the passive diffusion of a
solute from a vehicle into the skin are the physicochemical
properties of the vehicle, the diffusant and the skin. The
interaction of these three factors governs the rate or-arug
penetration.

In vitro percutaneous absorption of

benzocaine and other drugs in human cadaver skin have shown
that there is considerable variation in steady state
penetration rates, mostly attributable to the variability
in human skin due to any number of factors such as skin
age, skin condition, skin site, ethnic differences and skin
~-

metabolism. Thus the only valid comparisons are within the
same skin sample and from the same general area of the
body.
Propylene glycol has been reported to enhance
percutaneous absorption of medicaments solubilized in it
(28). Maximization of penetration rate from a vehicle
requires the proper balance between the solubility of the
drug in the vehicle and the skin/vehicle partition
coefficient. From a plot of solubility of benzocaine in
various propylene glycol/water mixtures and the partition
coefficients (between propylene glycol/water mixtures and
isopropyl myristate) against percent of propylene glycol, a
mixture of propylene glycol and water possessing an optimum

18

penetration rate could be projected. This approach provided
useful but empirical support to the selection of a 60/40
mixture of propylene glycol/water as the vehicle for
further experimentation.
Solubility Studies
The benzocaine solubility was determined in a series
of propylene glycol/water mixtures including the 60/40
mixture of propylene glycol/water containing one of the
three adjuvants, namely urea 11 , polyoxythylene (20)
isohexadecyl ether (PIE) 12 or 1-dodecylazacycloheptan-2-one
(Azone) 13 •
The solubility of benzocaine in 0%, 20%, 40%, 60%,
80%, and 100% propylene glycol in water at 25+0.5° is shown
in Table I. As can be seen, the solubility of benzocaine
increased with increasing concentration of propylene
glycol.
The solubility of benzocaine in a 60/40 mixture of
propylene glycol and water together with various adjuvants
was also determined. Increasing the concentration of urea
from 0.11g/ml to 0.44g/ml showed a marked increase in the
solubility of benzocaine (Table II). However, as can be

11.

'Baker analyzed' Grade, Lot. 8113703, J.T. Baker
Chemical Co., Phillipsburg NJ

12.

ICI Americas Inc. Lot. 4526B, Wilmington DE

13.

Nelson Research, Lot. 0157-132 Irvine CA

TABLE

I

SOLUBILITY OF BENZOCAINE IN PROPYLENE GLYCOL/WATER

SYSTEM~

AT 25 + 0.5°

SOLUBILITY (MG/ML)

PG/WATER V/V

100/0

123.75

80/20

46.40

60/40

17.00

40/60

7.75

20/80

4.25

0/100

2.00

I-'
\.0

I

TABLE II
BENZOCAINE SOLUBILITY IN PROPYLENE GLYCOL/WATERI160/ 40 SYSTEM
CONTAINING UREA AT 25+0.5°
CONC. OF UREA
(G/ML)

SOLUBILI*.
(MG/ML)

I

0.44

49.70

0.33

40.27

0.22

33.65

0.11

22.41
17.00

0

IV

0

I

i
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seen from the results given in Tables III and IV,
polyoxyethylene (20)

isohexadecyl ether and

1-dodecylazacycloheptan-2-one were less effective
in increasing solubility. Increasing percentages of
1-dodecylazacycloheptan-2-one showed

corresponding

increase of 34% in benzocaine solubility was obtained.
However, the solubility of benzocaine was found to
fluctuate between 17-28 mg/ml as the concentration of
polyoxyethylene(20) isohexadecyl ether was increased from 0
to 4 %.

.

-

TABLE III
BENZOCAINE SOLUBILITY IN PROPYLENE GLYCOL/WATER b0/40 SYSTEM
CONTAINING ARLASOLVE 200 AT 25 _::. 0.5°1
ARLASOLVE 200
(% W/V)

SOLUBILITY
(MG/ML)

4.00

24.29

3.00

28.02

2.00

22.72

1.00

19.99

0.75

20.74

0.50

25.22

0.25

18.87

0.10

20.18

0

17.00

N

N

:1'1

.I

l

TABLE IV
BENZOCAINE SOLUBILITY IN PROPYLENE GLYCOL/WATER[60/40 SYSTEM
CONTAINING AZONE AT 25 + 0.5°

SOLUBIL~:TY

AZONE
( %V /V)

(MG/Mlt)
II

10

22.4€!

5

17.3~!

1

16.41

I

16.3·1~

0.1

17.0~~

0

I

tv

w

1

m,:,.
I

,I,"
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Partition Coefficient
The partition coefficient values of benzocaine in the
two phase isopropyl myristate-propylene glycol/water system
containing 20%, 40%, 60% and 80% propylene glycol in water are
shown in Table

v.

These values were calculated as the ratio

of benzocaine in isopropyl myristate phase to the amount of
benzocaine remaining in

propyiene--g17co~--pnQ~B~he--------------------~

solubility and partition coefficients of benzocaine as a
function of percentage of propylene glycol in the solvent
mixture are shown in Figs. 1-5. The relationship between
solubility and the partition coefficient with the
increasing percentage of propylene glycol in the system is
graphically shown in Fig 1. and can be expressed by the
5-

following equations respectively:
ln(solubility)

=

0.041(% of PG) + 0.571

ln(partition coefficient)

=

-0.025(% of PG)

+ 1.510

As the percentage of propylene glycol in the vehicle increased,
the partition coefficient was decreased, confirming
the increasing tendency of the drug molecules to remain in
the vehicle with increasing fraction of propylene glycol in
the vehicle. This behavior negated the benefit resulting
from the increased solubility of the drug in the donor
phase. The choice of using isopropyl myristate as a
partitioning phase was based on the assumption that it
might mimic skin lipids and the stratum corneum (30). It is
possible that by using another phase system e.g. water/oil,

TABLE V
PARTITION COEFFICIENT OF BENZOCAINE IN ISOPROPYL MYR~STATE/PROPYLENE
GLYCOL-WATER SYSTEM at 22 + 0.5°
PARTITION COEFFICIENT

PROPYLENE GLYCOL
(% V/V)
100

0.204

80

1.133

60

1.432

40

1.358

20

2.808

0

3.897

N
Ul

I

,

Ul.ll ..

I
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100

•

•
O··\ '-o..~.----2...~-0__........._40--6._0__8...~-0_ ___.~10__,~0 l
%

Propylene Glycol

Fig. 1. Semi-log plot of solubility (•) and partition

coefficient (A) profile of benzocaine versus
percent propylene glycol
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Fig. 3. Plot of fraction of maximum solubility (e) and
partition (•) coefficient profile of benzocaine
versus percent propylene glycol
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that different values might be obtained. Moreover,
determination of the one vehicle with the optimum partition
and solubility characteristics based upon this approach
creates a real dilemma as can be seen from the various
plots (Fig 1-5). The theorectical bases of these various
plots were gleaned from previous works (28-30). The
majority of our plots predicted that a 60-70 percent
propylene glycol/water system should possess optimal
solubility and partitioning properties. Therefore, a
mixture of 60/40 (V/V) propylene glycol/water was chosen
for further investigations.

E-
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Penetration Studies
Unless otherwise indicated, all penetration studies
were initiated using the maximum possible concentration of
benzocaine in the vehicle. The penetration data were
analyzed by plotting Q (amount penetrated per unit area)
against time. A regression analysis of the data was

region of the penetration curve were calculated by a
computer. The different slopes were then compared to the
centro 1 by means of the t-test see if the 1 ines were
signifigantly parallel (statistical analysis program,
Appendix F). In order to overcome the differences of skin
samples from different donors and to establish a yardstick
to compare the results of various experiments, a standard
control with propylene glycol/water 60/40 (V/V) and 17
mg/ml of benzocaine was included in all experiments. The
observed penetration rates of the control range from a low
of 7.48 to a high of 16.48 mcg/cm 2 /hr with an average
of 11.93 mcg/cm 2 /hr. These variations in control values
could be explained on the basis of the variability of human
skin previously discussed. The relative rates were obtained by
dividing the rate for the control into the rates for the
test vehicles.
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In Vitro Percutaneous Penetration of Benzocaine from
Propylene Glycol/Water Mixtures
The first exploratory study of skin penetration of
benzocaine was done using different mixtures of propylene
glycol and water (80/20, 60/40, 40/60, 20/80). It has been
reported by Turi et al. (28) that propylene glycol

that skin resistence decreases as the percentage of
propylene glycol is increased. From the results, as could
be seen from Table VI and Fig. 6, there seems to be a
general trend in agreement with this hypothesis, but as the
concentration of benzocaine in each of the systems is
different, a direct correlation could not be made. It
should also be noted that the consistancy of the
thermodynamic flux was not maintained during the
penetration studies. However, there was no dramatic change
in the penetration rate as the percentage of propylene
glycol in the mixture was increased -- even though

)
1

statistically they were different (p<O.Ol) as compared to
the rate of penetration of the 60/40 (V/V) propylene
glycol/water mixture. The observed rate of penetration from
60/40 propylene glycol/water system did not correlate with
the empirically predicted optimum penetration rate based on
the solubility and partitioning studies

(Fig.

1).

Realistically, the true determination of partition
coefficient as it would relate to skin penetration could

TABLE

VI

PENETRATION OF BENZOCAINE FROM PROPYLENE GLYCOL/WATER S~STEMS THROUGH FULL
THICKNESS HUMAN SKIN
PG/WATER SYSTEM
(V/V)

RATE
(MCG/CM 2 /HR)

CORRELATION
COEFFICIENT

LAG TIME
(HR)

80/20

8.54 (..:!:_0.22)

0.998

0.24

60/40

7.48 (..:!:_0.20)

0.998

-0.13

40/60

6.61 (..:!:_0.23)

0.997

-0.60

20/80

8.93

0.955

-0.13

(..:!:_1.23)

Number in parentheses indicate the 95% confidence limit

I

o~

the respective slope.

Benzocaine was near saturation in the above solutions.
The rates from propylene glycol/Water 80/20, 40/60, 20/80; were
signifigantly different (p<0.01) as compared to propylenelglycol/water 60/40.
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. Fig. 6. Penetration of benzocaine from propylene glycol/
water systems through full thickness human skin
Q versus t plot
Key: % Propylene glycol/water (V/V) ~80/20
• 60/40
a 40/60 o 20/80
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only be obtained between the vehicle and isolated stratum
corneum.

s-
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In Vitro Percutaneous Penetration of Benzocaine from
DMSO/Water Mixtures
DMso 14 did not enhance the penetration of benzocaine
into the stratum corneum as compared to the control of
60/40 propylene glycol/water as shown in Table VII, Fig. 7,
(p>0.05). This could be due in part to the increased
solub1l1ty of benzoca1ne

iilln1~o7water

system

ana--------------------~

consequent decrease in partitioning of benzocaine into the
receptor skin. While the concentration of 17mg/ml of
benzocaine was at saturation level for the propylene
glycol/water system and thus had a higher thermodynamic
flux to penetrate into the skin, such was not the case with
respect to benzocaine in DMSO/water mixture. On the other
hand, it has been shown by some authors (11) that in order
for DMSO to enhance penetration of certain compounds, a
critical percentage of DMSO (60-80%) is necessary. The
previously discussed phenomenon of increased hydration of
the skin by DMSO could lead to dilution of medicaments
applied on the skin thus underscoring the importance of
proper experimental design based upon constant
thermodynamic flux throughout the duration of release.

14. 'Baker analyzed' grade, Lot. 8216688, J.T. Baker
Chemical Co., Phillipsburg NJ

TABLE

VII

PENETRATION OF BENZOCAINE FROM DMSO/WATER SYSTEMS [THROUGH FULL
THICKNESS HUMAN SKIN.
DMSO/WATER SYSTEM
(V/V)

RATE
(MCG/CM 2 /HR)

RELATIVE
RATE

coJ.RELAT I ON
CO,FFICIENT

LAG TIME
(HR)

80/20

16.06 (.!_3.17)

0.995

0.919

-0.36

60/40

14.39

(.!_3.41)

0.892

0.882

-0.93

40/60

17.28 (.!_2.05)

1.071

0.966

-0.19

20/80

15.58 (.!_0. 73)

0.965

0.994

0.09

CONTROL

16.14 (+0.74)

1

0.995

-0.59

Control

=

propylene glycol/water 60/40.

Concentration of benzocaine in all systems was 17mg/ml.
The rates of all DMSO/Water curves did not show any
compared to control (p<0.05).

signif~gant

I

difference as

The numbers in parentheses indicate 95% confidence limits pf the respective
slope.
w
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Fig. ? •. Penetration of benzocaine from DMSO/water
systems through full thickness human skin
Q versus t plot
Key: % DMSO/water {V/V)
~:>. 80/20
o 60/40
o 40/60 • 20/80 • Control
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Effect of Urea on the Percutaneous Penetration of
Benzocaine
Urea was incorporated into propylene glycol/water
60/40 mixture in the following amounts: O.llg/ml,

0.22g/ml,

0.33g/ml, 0.44g/ml. The saturation solubility of urea in
propylene glycol water 60/40 mixture was determined to be

Fig. 8, urea did not enhance the penetration of benzocaine;
in fact, it appeared to retard the penetration of
benzocaine. This lack of enhancement could be due to the
increased affinity of benzocaine for the vehicle containing
urea thus reducing the partitioning of benzocaine into the
skin. Inadequate thermodynamic flux might have contributed
to the findings. Feldman and Gibaldi (23) have reported
that urea effectively breaks up the clusters of hydrogen
bonded water surrounding the nonpolar molecules in aqueous
solution resulting in an increase in the entropy of the
system thus providing the energy for breaking up of
hydrophobic bonds between nonpolar molecules. The net
result is an increased solubility of nonpolar molecules in
the aqueous medium.
In the second set of experiments with urea (Table IX,
Fig. 9), there was initial saturation of benzocaine with
respect to each of the solutions. In this case, the urea
enhanced the initial penetration of benzocaine into the
stratum corneum (Fig. 10), but after the initial hour, all

TABLE

VIII

PENETRATION OF BENZOCAINE FROM PG/WATER 60/40 SYSTEtvl CONTAINING UREA
THROUGH FULL THICKNESS HUMAN SKIN: f

I

CONC. OF UREA
(G/ML)

RATE
(MCG/CM 2 /HR)

RELATIVE
RATE

CORRJ~LATION

COEF,,ICIENT

LAG TIME
(HR)

-~

0.44

11.73 (.2:_2.43)

0.878

0.~~96

0.33

14.93 (.2:_2.61)

1.118

0.997

0.22

14.51 (.2:_0.84)

1.087

O.l~99

0.11

15.98 (.2:_2.45)

1.197

0.1~98

13.36 (.2:_1.13)

1

0.999

CONTROL

I

I

I

-2.10
-1.52
0.20
-1.25
-0.52

I
Control

=

propylene glycol/water 60/40 V/V.

Concentration of benzocaine in all systems was 17 mg/ml.
Maximum solubility of urea in propylene glycol/water 60/4r was 0.44 g/ml.
The rates of benzocaine penetration from all vehicles were significantly
different from control (p<0.01) •
The numbers in parentheses indicate 95% confidence limits! of the respective
slopes.
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Fig. 8. Penetration of benzocaine from propylene
glycol/water 60/40 system containing urea
through full thickness human skin: I Q versus t plot
Key: Cone. of urea (g/ml)
• 0.44 o 0.33
• 0.22 ~ 0.11
• Control

TABLE

IX

PENETRATION OF BENZOCAINE FROM PROPYLENE GLYCOL/WATER 60/~0 SYSTEM CONTAINING
UREA THROUGH FULL THICKNESS HUMAN SKIN: I I
CONC. OF UREA
(G/ML)

RATE
(MCG/CM 2 /HR)

RELATIVE
RATE

CORREL~TION

COEFFIFIENT

LAG TIME
(HR)

0.44

14.72 (_!.0. 71)

0.958

0.9r

-0.13

0.33

12.88 (_!. 2 • 3 7)

0.838

0.9 6

0.35

I

I

0.22

16.68 (_!.0.79)

1.085

0. 9914

0.31

0.11

14.09 (_!.0.44)

0.917

0.9j7

0.33

15.37 (_!.0.90)

1

CONTROL

Control

=

0.9r

-0.04

propylene glycol/water 60/40 V/V.

Concentration of benzocaine in all system were near
the solution.

satur~tion

I

with respect to

Maximum solubility of urea in propylene glycol/water 60/40 was 0.44 g/ml.
The rates of benzocaine penetration from all Vehicles werl significantly
different from control (p<0.01) except the vehicle contai~ing 0.44gm/ml urea
which was not signifigantly different (p>0.05).
The numbers in parentheses indicate 95% confidence limits! of the respective
slopes.
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Fig. 9. Penetration of benzocaine from propylene
glycol/water 60/40 system containing urea
through full thickness human skin: II Q versus t plot
Key: Cone. of urea (g/ml)
• 0.44 o 0.33
• 0.22 ~ 0.11 • Control
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Fig. 10. Initial penetration of benzocaine from
propylene glycol/water 60/40 system containing
urea through full thickness human skin: II Q versus t plot
Key: Cone. of urea (g/ml) • 0.44 o 0.33
• 0.22 ~ 0.11 • Control
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the rates were essentially the same. The observed biphasic

f

nature of the penetration curve could be due to drug loss

(

J

from the donor solution. The hydration effect of urea on
stratum corneum could be a time-related phenomenon. Thus if
the skin was pretreated with urea solution and the penetration
experiment conducted, the enhancement effect of urea might
be more pronounced. However, urea did not exer·
penetration enhancing effect even with increased
concentration of benzocaine.

rr~poten~~~a~~--------~
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Effect of Polyoxyethelene

Isohexadecyl Ether on the

Percutaneous Penetration of Benzocaine
Polyoxythylene (20)

isohexadecyl ether (PIE) , a

nonionic surfactant has been marketed as a solubilizer
(31). The critical micelle concentration (CMC) of PIE was
found to be between 0.005-0.009% (W/V). This was in
agreement Wl
supplier (0.005-0.01%) (31).
The results shown in Table X and Fig. 11 revealed that
PIE retarded, rather than enhanced, the penetration of
benzocaine through full thickness human skin in the
concentration range studied. This could be due in part to
micellar solubilization of the drug. The resulting decrease
in partitioning of benzocaine into the skin coupled with
decreasing thermodynamic flux could account for the
observed effect.

The penetration rate of benzocaine was

found to decrease as PIE concentration approached the CMC
and increased as it exceeded the CMC. Above the CMC, less
surfactants are available for interaction with the skin,
provided that PIE does interact with the skin. This effect
in conjunction with the previouly discussed phenomenon of
micelle formation, might be used to explain the change in
penetration rate of benzocaine around the CMC.

The

penetration rate of benzocaine from the PIE formulations
was signifigantly (p<0.01)

lower than from the control.

Dalvi and Zatz (21) while studying nonionic surfactant

TABLE X
PENETRATION OF BENZOCAINE FROM PROPYLENE GLYCOL/WATER 160/40 SYSTEM WITH
ARLASOLVE 200 THROUGH FULL THICKNESS HUMAN SKIN
ARLASOLVE 200 CONC.
(% W/V)

RATE
(MCG/CM 2 /HR)

RELATIVE
RATE

CORs~ELATION
COEF(ICIENT

LAG TIME
(HR)

0.0008

15.87

(~ 0.

9 9)

0.967

OJ990

0.37

0.005

14.18

(~ 1.17)

0.882

01983

-0.11

0.007

10.60

(~1.95)

0.646

0.924

-0.14

0.009

14.63

(~1.43)

0.892

ol979

-0.07

0.07

15.23

(~3.59)

0.934

ols83

-0.02

16.41

(~5.78)

1

ol799

-0.47

CONTROL

I

Control= propylene glycol/water 60/40 (V/V).
Concentration of benzocaine in all system was 17 mg/ml.
CMC of Arlasolve 200 was within the range 0.005 - 0.009%.
The rates of benzocaine penetration of all vehicles were
different from the control (p<0.01).

~ignifigantly

The numbers in parentheses indicate 95% confidence limits! of the respective
slopes.

~
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Fig. 11. Penetration of benzocaine from propylene
glycol/water 60/40 system with PIE through
full thickness human skin : Q versus t plot
Key: Cone. of Arlasolve 200 (W/V)
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effects on the penetration of dissolved benzocaine through
hairless mouse skin observed that penetration flux from
solutions containing a fixed benzocaine concentration was
inversely related to surfactant concentration. For
solutions saturated with benzocaine, surfactant
concentration did not influence the benzocaine flux. The
penetratio-n

o£-n-e~~~o~a~~--wag-plLo~urt~-ona-r-co--ch~~re~--------------

benzocaine concentration. Benzocaine solubilized by
micellar entrapment would not be available for skin
penetration. The foregoing interpretation by Dalvi and Zatz
could not be applied directly to the PIE data in view of
widely different levels of surfactant concentrations
employed in the two studies and the difference in
permeability of hairless mouse skin as compared to human
skin. Their studies also employed significantly higher
levels of surfactant concentration (1-5% W/V). It would
appear that surfactant effects on penetration rate at and
around CMC are also related to free drug concentration.
Additional studies covering a wider range of PIE
concentrations with varying drug concentration are
warranted in order to fully understand the nonionic
surfactant effects of PIE on drug penetration.
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Effect of Azone on the Percutaneous Penetration of
Benzocaine
Azone

(1-dodecylazacycloheptan-2-one) has been

reported to enhance the percutaneous absorption of a
variety of drugs (14-16). Azone was found to be immiscible
with water or other polar solvents or their mixtures. In
order to fac1l1tate 1ts incorporation into our system of
propylene glycol/water 60/40, an emulsion and a gel were
formulated. Since PIE was used previously and its
percutaneous penetration characteristics were known, a
formulation using it as a surfactant/emulsifier was
prepared. The gel system was prepared with Klucel LF
(hydroxypropyl cellulose) 15 ,

as it provided the desired

viscosity at the concentration chosen. The four
concentrations of Azone studied were 0.1%, 1%, 5%, and
10% (V/V).
1. Azone in an emulsion vehicle with PIE
As could be seen from Table XI and Fig. 12, Azone
appreciably enhanced the penetration of benzocaine through
full thickness human skin. The rate of penetration in the
steady state region was greatest with 5% Azone (5%
10% > 0.1% > control).

> 1% >

However in the initial two-hour

period (Fig. 13), the rate was greatest with 1% Azone (1% >
5%

=

0.1%

> 10% > control). It is interesting to note that

15. Grade MF, Lot. 2981, Hercules Inc., Wilmington DE

TABLE XI
EFFECT OF EMULSIFIED AZONE ON PERCUTANEOUS PENETRAT]ON OF BENZOCAINE
FROM PROPYLENE GLYCOL/WATER 60/40 SYS1EM
CONC OF AZONE
(% V /V)

RATE
(MCG/CM 2 /HR)

.

--;~~ATI;E
RATE

CORRElATION
COEFFiCIENT

LAG TIME
(HR)

I

13.60 (.:!:_1.84)

1.296

o.l6s

1.17

5%

21.63

(.:!:_2.21)

2.062

o.J87

1.77

1%

16. 71 (.:!:_1. 2 5)

1.593

o.J87

-1.71

0.1%

12.80 (.:!:_0.50)

1.220

o.!97

-0.26

10.49 (.:!:_0.31)

1

o.!97

-0.23

10%

CONTROL

I

Control

=

propylene glycol/water 60/40 (V/V).

Concentration of benzocaine in all system was 17 mg/ml.
0.5%

(W/V) Arlasolve 200 was used in all systems to emulsify azone.

The rates of all the Azone curves were signifigantly diffirent from the
control curve (p<0.01).
The numbers in parentheses indicate 95% confidence limits! of the respective
slope.
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Fig. 12. Effect of emulsified Azone on percutaneous
penetration of benzocaine from propylene
glycol/water 60/40 system : Q versus t plot
Key: Cone. of Azone (V/V) o 10% a 5%
• 1%
• 0.1% • Control
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Fig. 13. Initial effect of emulsified Azone on
percutaneous penetration of benzocaine
from propylene glycol/water 60/40 system
Q versus t plot
Key: Cone. of Azone (V/V)
o 10% o 5%
• 1% • 0.1% • Control
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Azone also overcame the mildly inhibiting effect of PIE on
the penetration rate of benzocaine.
2. Azone in a gel system with 4%W/V Klucel LF
Azone was found to enhance the percutaneous
penetration of benzocaine. The rate of enhancement in the
steady state region was greatest with 5% Azone (5%
0 .1%

>

1 0%

>

> 1% >

con tro 1) • Ag a l.n, s i mr1 ar re s-u-1--c-s-we-re-ob-t-a-i-nea~----~

in the initial two-hour period as obtained from the
emulsion system (Table XII, Fig 14), i.e. Azone was the
most effective enhancer at 1% concentration during the
early stages (Fig. 15) of drug penetration (1%

>

10%

>

0.1%

> 5%

> control).

3. Gel system with excess of benzocaine.
In view of the promising potential of Azone as a
penetration enhancer for benzocaine as determined from the
previous two sets of experiments, a formulation of
propylene glycol/water and azone with excess benzocaine was
prepared. The excess benzocaine in the system provided
maximal thermodynamic flux throughout the penetration
period.

The resultant penetration curve was biphasic with

two distinct steady state regions (Table XIII, Fig. 16-17).
This could be due to some artifact of the skin sample used
or to the enhancement mechanism of Azone at work. The
concentration of Azone that seems to provide the maximal
penetration rate was 5%.

TABLE XII
EFFECT OF GELLED AZONE ON PERCUTANEOUS PENETRATIO~ OF BENZOCAINE
FROM PROPYLENE GLYCOL/WATER 60/40 SYSTEM
CONC. OF AZONE
{%V/V)

RATE
{MCG/CM 2 /HR)

RELATIVE
RATE

CORRE!LATION
COEF,ICIENT

LAG TIME
{HR)

10%

9.11 {.:!:_0.17)

1.205

oL98

-0.77

5%

17.04 {.:!:_1.06)

2.254

oJ.998

1.20

1%

16.36 {.:!:_0.97)

2.164

0 .l997

-1.10

0.1%

11.42 {.:!:_0.54)

1.511

o/.998

0.29

1

Of999

-0.72

CONTROL

Control

=

7.56 {.:!:_0.19)

propylene glycol/water 60/40 {V/V) with 4%

Kluc~l

LF.

Concentration of benzocaine in all system was 17 mg/ml.
The rates for all azone containing system were signifiganltly different from
the control {p<0.01).
The numbers in parentheses indicate 95% confidence
slopes.

limit~

of the relative
Ul
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Fig. 14. Effect of gelled Azone on percutaneous
penetration of benzocaine from propylene
glycol/water 60/40 system : Q versus t plot
Key: Cone. of Azone (V/V)
o 10%
o 5%
• 1%
• 0.1% • Control
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Fig. 15. Initial effect of gelled Azone on
percutaneous penetration of benzocaine
from propylene glycol/water 60/40 system
Q versus t plot
Key: Cone. of Azone (V/V)
o 10% o 5%
• 1%
• 0.1% • Control

TABLE XIII
EFFECT OF GELLED AZONE ON PERCUTANEOUS PENETRATION OFIBENZOCAINE FROM
PROPYLENE GLYCOL/WATER 60/40 SYSTEM WITH EXCESS BENZOCAINE
RATES
(MCG/CM 2 /HR)

CONC. OF AZONE
(% V /V)

27.63

0.1%
CONTROL

= propylene

14.24

(~1.15)

(~9.

9.11 (+0.53)

17.11

9.99

16.09

(~0.54)

II

0.969

0.987
0.999

19.25

(~1.

I

(~0.37)

73)

15.50

1%

Control

(~7.06)

19.29

5%

r-r

II

I
10%

CORRELATION
COEFFICIENT

I

0.979

0.850

(~3.06)

0.995

0.969

(~0.61)

0.996

0.999

74)

glycol/water 60/40 (V/V) with 4% Kluc,l LF.

Concentration of Benzocaine in all formulations was 50 mgAml.
The numbers in parentheses indicate 95% confidence limits/of the respective
slopes.
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Fig. 16. Effect of gelled Azone on percutaneous
penetration of benzocaine from propylene
glycol/water 60/40 system with excess
benzocaine : Q versus t plot
Key: Cone. of Azone (V/V) o 10% o 5%
• 1% • 0.1% • Control
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Fig. 17. Initial ~ffect of gelled Azone on
percutaneous penetration of benzocaine
from propylene glycol/water 60/40 system
with excess benzocaine : Q versus t plot
Key: Cone. of Azone (V/V) o 10% o 5%
• 1%
• 0.1% • Control

62

4. Azone in a gel system with excess benzocaine with
various percentage of propylene glycol.
These sets of experiments were conducted since
propylene glycol has also been reported to possess some
concentration dependent percutaneous enhancement effects of
its own (28). Since 5% Azone was the concentration that
exerted this maximal penetration enhancement

effece~,~a~----------------~

series of gelled formulations with increasing percentages
of propylene glycol were prepared with 5% Azone, and
percutaneous penetration of benzocaine investigated to find
the optimal propylene glycol concentration. The
concentration of benzocaine employed was in excess so as to
provide for maximum thermodynamic force. The data presented
in Table XIV and Fig. 18 reveal that rate of penetration of
benzocaine is favored by increasing the concentration of
propylene glycol.
From these experiments, it can be concluded that Azone
exhibits a concentration-dependent enhancement of
percutaneous penetration of benzocaine. At 10% Azone in the
formulation when benzocaine level was not at saturation,
Azone was able to overcome this thermodynamic deficit and
still enhance the penetration. The biphasic nature of the
penetration curves may be suggestive of but not conclusive
of a change in mechanism of penetration of benzocaine in
the presence of Azone. In each of the experiments with

TABLE

XIV

PENETRATION OF BENZOCAINE FROM GELLED PROPYLENE GLYC~L/WATER SYSTEMS
WITH 4% KLUCEL LF AND 5% AZONE THROUGH FULL THICKNtSS HUMAN SKIN

.

PG/WATER SYSTEM
(V/V)

RATE
(MCG/CM 2 /HR)

I

RELATIVE
RATE

CORRELATION
COEFF[CIENT

LAG TIME
(HR)

I

80/20

55.37 (_::2.89)

2.496

0.~99

3.67

60/40

38.37 (_::2. 31)

1.730

0.1999

3.49

40/60

45.26 (+1.49)

2.041

0.19 9 9

2.39

20/80

40.00 (+1.05)

1.803

2.89

0/100

34.98 (_::0.79)

1.577

o. 999
o. 997

2.65

0/100[NO AZONE]

22.18 (_::0.94)

1

0. 999

2.08

All of the above formulations contain 60 mg/ml of benzocaJne.
All the rates were signifigantly different from the
0/100 control with no Azone.

propy~ene

glycol/water

The numbers in parentheses indicate 95% confidence limitslof the respective
slopes.
0'\
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Fig. 18. Penetration of benzocaine from gelled
propylene .glycol/water systems with
4% Klucel LF and 5% Azone through full
thickness human skin : Q versus t plot
Key: % Propylena glycol/water- (V/V) o 80/20
• 60/40 c. 40/60 Cl 20/80 • 0/100
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Azone, there was definite enhancement in the initial two
hour period before steady state was reached. The pattern of
high initial rates followed by slightly lower steady-state
rates later suggests that Azone produces significant
structural changes in the stratum corneum, lowering its
resistance to drug penetration. However, these changes are
possibly reversible due to dilution dur1ng

sub~s-e-q-a-e-nt~---------~

equilibrium. If Azone is bound to the epidermis, it may
create channels in between the flattened cells of the
stratum corneum and allow for the passage of solubilized
drugs. Through gross examination of the stratum corneum at
the end of each set of runs, the stratum corneum was found
to be intact with no visible changes. While our findings
corraborate the results of other workers (14,15) as to the
enhancement effect of Azone, they have failed to provide
any additional insights into the mechanism of action of
Azone. Further research mainly directed towards this goal
is strongly recommended.
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CONCLUSIONS
The in vivo lack of efficacy of benzocaine during
clinical trials of many OTC products has been reported by
various authors (3,7,33). This is in part due to the fact
that benzocaine does not effectively penetrate the stratum
corneum. In the present stu y, tlie efrect:s

of-a-n-uln~be-r-o-f-------'

dosage form-related parameters were investigated with a view
to enhance penetration of benzocaine topically in order to
achieve rapid relief from itch and pain.
1. Benzocaine solubility and partitioning
characteristics in propylene glycol/water solvent
systems were studied to enable identification of
optimum levels. The in vitro findings with human
cadaver skin did not support the empirical prediction
of the partitioning study. This lack of predictability
demonstrates the limitations of a simple two-phase
system. However, if partition studies were performed
using isolated stratum corneum, better predictive
capability might be expected.
2. The in vitro penetration studies strongly suggested
that thermodynamic flux should be maintained at a
constant during the penetration period to achieve
optimal results and to allow one to draw meaningful
conclusions regarding penetration enhancement effects.
3. Of the various adjuvants investigated, Azone was
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found to be the most effective penetration enhancer
fo~

topical benzocaine. It appears to have its maximal

effect on steady-state rates at a 5% V/V concentration
and on initial rates of penetration at even lower
Azone levels

(1% V/V).

4. Under the conditions of the experiment, DMSO did
not enhance top1cal

penetra~ion

~f--~e~u~a±ne~~--------------~

definitive conclusion must await further studies under
conditions of constant thermodynamic flux together
with higher percentages of DMSO.
5. Interestingly, urea was found to enhance benzocaine
penetration initially during the first hour only. The
lack of any significant steady-state rate enhancement
by urea even at saturated levels of benzocaine could
be explained on the basis of a shift of thermodynamic
flux as the experiment progressed.
6. The results with polyoxyethylene (20) isohexadecyl
ether are inconclusive since study was conducted over
a narrow range of surfactant concentration. A proper
understanding of its observed effects requires a more
rigorous investigation of its effects on solubility
and partitioning of benzocaine.
7. Propylene glycol did exhibit some penetration
enhancement effect. This effect was additive in
the experiments with azone.
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In vitro penetration studies have intrinsic
limitations and the results of this investigation presently
serve only as guidelines for further in vitro studies. The
variability of the skin samples and even the variability
within one skin sample and the chosen experimental design
preclude drawing definitive conclusions at this time.
Nevertheless it is generally

agreed-Ehat--i~~Lv,----------------------~

experiment on human cadaver skin are far more reliable
indicators of clinical action than in vitro models
utilizing animal skins.
A propylene glycol/water mixture has been shown to be
a suitable vehicle for topical application of benzocaine.
Results indicated that favorable solubility, partitioning
and skin penetration could be obtained from such a system.
The classical approach of adjusting the physico-chemical
properties of the solvent system to that of the drug and
the skin in order to enhance percutaneous absorption has
been validated by this study.
Significantly high initial rates of penetration of
benzocaine with Azone strongly warrant further in vitro and
in vivo examination • If the observed findings are
corroborated in vivo, a successful commercial product is a
real

possibility.

\
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APPENDIX A: Beer 1 s law plot of benzocaine in
propylene glycol/water 100/0 (V/V);
each point represents the average of
three determinations.
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APPE:mrx B: Beer's law plot of benzocaine in
propylene glycol/water 80/20 (V/V);
each point represents the average of
three determinations.
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Beer's law plot of benzocaine in
propylene glycol/water G0/40 (V/V);
each point represents the average of
three determinations.
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APPE~DIX D:

Beer's law plot of benzocaine in
propylene glycol/water 40/60 (V/V);
each point represents the average of
three determinations.
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each point represents the average of
three determinations.
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APPENDIX G
Modified computer analysis Pl""ogram from
Cal CLll ati ons t.-Ji th CompLlter F'rogr ams 11
by R. J. Tallarida and R. B. Murray <3S)

20
30
40
50
60
70

11

l'1anLlal • of F'hannac:ol og i cal

REM
-------MAIN ROUTINE-------CLEAR 500
DEFINT I~J~L~N
DIM DA<40,20>, SRSC34)~ XC40)~ VC40), TBC101>
ON ERROR GOTO 50000
SC$=
F'HAF:MACOLOG I c CACULAT I ON PROGF:AM) ) +STF: H.IG$ ( 63,
II )
{------H~;'-.c:~._I,I-.~.:f"~U.~,~$-t'.Z~~l--:-R,G:~l~NT-SC$~; ''
I !'UJ"_IALl_Z I·~~~==~~------------~
NG PROGRAM ''
90 LS=12:REM
LINES/SCREEN
100 ID=O:REM
DATA FLAG
110 F:ESTOF:E
120 IL=I:READ I~SRS<I>:IF I<>O THEN 120
130 SR$ ( I L + 1 ) =II EI\ID F:EI'1
LAST SF:S
140 I=l:LC=O
150 PRINT CHRSC26>:PRINT SC$
160 IF SF:$ (I) ="END" THEN I=1: LC=O: GOTO 200
170 IF SF:$ (I)<> II
THEN F'F: I NT I; II- II; SF:$ (I) : LC=LC+ 1
180 I=I+l
190 IF CLC/LS=INTCLC/LS)~ AND LC<>O THEN 200 ELSE 160
200 JF'=2:U=255:PRINT
210 L$=" 11 : PN$= 11 " : PX$=" INDEPENDENT ',iAF:IABLE 11 :
PY$= II DEF'ENDEI'.IT '/AF: I ABLE II
220 PRINT:PRINT ''ENTER PROCEDURE # OR <RETURN> FOR NEXT PAGE ==>II;
230 U=O: INPUT U:REM
ENTER SR#
240 IF U>O AND U<34 THEN 260
250 GOTO 150
260 PRINT CHRSC26>:TT=C54-LEN<SR$CU)))/2
210 PF:INT TAB <TT>; II< # 11 ; u; ~~- II; sRs w>;" >II: PRINT
280 ON U GQSUB 1000~2000,3000,4000~5000~6000,7000,8000~9000,
II

(

(

II

II-

0

II :

II

1

10000,11000~12000,13000,14000,15000,16000,17000,18000,

19000,20000
.
290 IF U<20 GOTO 310
300 ON U-20 GOSUB 21000,22000~23000,24000,25000,26000,27000,
28000~29000~30000~31000,32000~33000

:310 I=1
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320
330
500
510
520

GOTO 200
REM
CCOMMON SUBROUTINES>
F'F: I NT: I NF'UT II F'F:ESS ( ENTEF:) TO CONTI 1\!UE II ; E$: F:ETUF:N
REM
<CONVERT TO LOGC10))
FOR I=i TO N(J):DA<I~J)=LOG<DA<I~J))/LOG<10):NEXTI:ID=O:
F:ETUF:N
530 REM
<PRINT CALC VALUES ? >
540 F'F::INT:AS= 11 ":!NPUT"PF:INT CALCULATED VALUES (Y/N) ";
AS:AS=LEFTSCA$,1)
550 F'RINT:RETURN
560 REM
<CALC NEW VALUES ? >
570 F'F:INT: PF:INT"ENTEF: NUMBEF: TO CALCULATE NE~J '·JALUES OR
(099) TO CONTINUE."
580 F:ETURN
590 INPUT X:RETURN
600 REM
CPRINT X Y MESSAGE>
610 IF PXS<>XL$ OR PYS<>YL$ THEN PRINT:
F'F:INT 11 NOTE: X= ";PX':!i;:PF:INT TABC36);".,( = "~pv·s:F'RINT
620 XL$=PXS:YL$=PYS:RETURN
700 REM
<INPUT DATA>
710 L=O
·720 ID=O
730 )(L$=" 11 :YL$= 11 "
740 J=O:N<l>=O:I=O
750 GOSUB 610
780 IF L< >O THEN 800 ELSE PRINT"ENTEF: NUMBEF: OF";
785 IF L$< >1111 THEN PF:INT L$;: ELSE
IF JP=1 THEN PF:INT"GROUPS OF DATA
";:ELSE
IF JF'=2 THEI'.I F'F:INT"LINES OF: CURVES II;
790 INPUT L:L=L*JP
800 FOR J = 1 TO L STEP JF'
805 PF: I NT II ENTEF: NUI'1BEF: OF II
810 IF F'N$< > I I II THEN F'F: :r I'.IT F'N$; :. ELSE
IF JP=1 THEN F·F:INT 11 0BSERVATION OF GF:OUP #";J;:ELSE
IF JP=2 THEN F'F:INT 11 0BSEF:Vf'=.iTION OF LINE OF: CUF:VE #"; (j"+l) /2;
840 INPUT N:IF N<=O THEN 805
850 IF 1\1 >100 THEN PF: I I\IT II N 1'1UST BE LESS THAN 100. II : GOTO 805
860 NCJ>=N:IF JP=2 THEN N(J+i)=N
870 FOR I = 1 TO N<J>
880 IF JP=2 THEN PRINT 11 ENTEF: X~ Y PAIF: ~*";I;
:INPUT DA<I~J)~DA<I,J+1>:GOTO 910
890 PF: I NT II ENTEF: OBSEF:VAT I ON #II ; I ;
900 INPUT DACI~J)
'1'10 NEXT I, J
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920
930
940
950
960
970
980
990

DATA ?
IF L=O THEN RETURN:REM
FOF: J=1 TO L
F'F:II\tT: F'F:INT"GF:OUF' #"; J; II: II;
FOR I=1 TO N<J>:F'RINT DA<I~J>;:NEXT I
NEXT J
ID=l:REM
SET DATA FLAG
PF: I 1\tT: PF: I NT
F:ETUF:N

2000 DATA

2~ "MEAN~

STANDAF:D DEVIATION

~/,

CONFIDENCE LIMITS"

l------'+2t)::~{~>-8-8BbJE~l-(-}t~-------------------------~

2050
2060
:2100
2200
2210

C30SUB 2600
F:ETURN
JF'=1:F'X$= :F'Y$=" :GOSUB 710
FOR J=1 TO L
GOSUB 2660

222(>

t~.tE:~T

1111

11

2230
2600
2605
2610
2620.
2630
2640
2650
2660
2670
2680
2690
2700
2710
2720
:2730
27 40
2750
2760
:"2:770

F:ETUF:N
N=N<1>-1:GOSUB 2960
GOSUB 2790
FOR J=1 TO L
GO SUB 281 0
NEXT
F:ETUF:N
Jl=J:GOSUB 2660:J=J+1:GOSUB 2660:J=J1:RETURN
N=NCJ):X=O:SX=O:ME=O:S2=0:DE=O:DS=O:SE=O:VA=O
FOR I=1 TO N
X=DA<I,J>:SX=SX+X:S2=S2+X*X
NEXT
ME=SX/N
FOR I=l TO N
X=DACI,J>:DS=DS+(X-ME)*(X-ME>
NEXT
~/A= OS/ ( !'.1- :L )
DE=SQF: (VA)
SE=DE/SQR<N>
SX ( J) =S X: 82 ( J) =S2: DE ( J) =DE: DS <J) =DS: VA ( J) =VA: r1E ( J) =
ME:SE<J>=SE
2780 F:ETUF:N
T '-/ALUE
!"lEAN
2790 PF: INT CHF:$ <27) +"1
#
N SUI"!
STD DEV STD EF:F:
CHF:$ <27) + m
2800 F:ETUF:N
11

;

11

II

11

;

11

+/-
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2810
2860
2870
2880
2890
2900
2910
2920
2950
2960

N=NCJ>:DE=DECJ)
N=N-1:GOSUB 2960
PRINT J;TAB<3>NCJ);
CL=T~J*SE <J l
PRINT TAB<5>;SX<J>;TAB<15l;ME<J>;TABC24>;TV;
PRINT TABC33);CL;
PRINT TAB<42>;DE<Jl;TAB<51J;SE(J)
F:ETUF:N
REM FI$ MAY BE CHANGED TO A T TABLE FILE FOR P=99
IF N>30 THEN TV=i. 96 ELSE FI':tl="TTABLE/P95
11

:

2999 F:ETUF:N
3000
3030
3040
3050
:3060
3200
3210
3220
3230
3240
3250
:3260
3270
3280
3290
3300
:3310

LH.tEAF: F:EGF:ESSIOI'.I I
GOSUB 710:REM INPUT
GOSUB 3200:REM PROCESS
GOSUB 3800:REM OUTPUT
F:ETUF:N
GOSUB 2·200
FOR J=l TO L STEP 2:GOSUB 3230:NEXT J
F:ETUF:N
N=N<J>:X=O:SX=SX<J>:XM=MECJ):X2=S2CJl:Y=O:SY=SXCJ+1):
YM=MECJ+1l:Y2=S2CJ+1l:XY=O:M=O:B=O
FOR I=l TO N<Jl
X=Df=1 (I~ J)
Y=DA CI, J+l)
XY=XY+CX*Yl
NEXT I
M=<<SX*SY/Nl-XYl/((SXA2/Nl-X2)
!VI ( J ) =tv!
B=YM- <M*Xl'1)
DATi~

3~

11

II

332() B (J) =B
333C>
< J) =X\'
335() F~ETUF!I'~

x·\r

3800
3810
:3820
39:.::.o
3840
:3850

FOR J=l TO L STEP 2:GOSUB 3830:NEXT J
GOSUB 3860
F:ETURN
aosue 610: PF:INT F:EGF:ESSION LINE #" ~: <J+l > /2; ":
PF: I NT y =
M( J) ;
X +
B ( J)
F:ETUF:N
11

II

II ;

II*

II;

II ;

·..
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3860 GO SUB 540: IF A$< >II y II THE!'•.! F:ETURN
3870 FOR J=l TO L STEP 2:GOSUB 3880:NEXT J:RETURN
3880 PFUNT 11 LINE #"; <J+i) /2~ "OBSEF:VED X", "OBSEF:VED Y",
"C,~LCULATED

3890
3900
391 o
3920
3930
:3940
:3950
3960
3999
4000
4030
.4040
4050
4060
4800
4810
4820
4830
4840
4850
4860
4870
4880
4890
4910
4920
49:::;:0
4940
4950
4960
499!7

Y

11

FOR I=l TO N<J>
YC=M(J)*DA<I,J>+B(J)
PF: r NT II I I , DA < r, J) :• D1::. <I :• .J + 1 > , vc
NE)(T I
t31JSUB 570
F'R I NT II II~ : GOSUB 5'?0: IF X=999 THEN F'FU NT: GOTO 3999
'·(C=M ( J) *X +B ( J) : PF: I NT II II, X, "II, YC
GOTO 3940
F:ETUF:N
DATA 4, "LINEAR F:EGRESSIOI'.I I I: LINES THF:OUGH OF:IGHl"
GOSUB 710:REM INPUT
GOSUB 3200:REM PROCESS
GOSUB 4800:REM OUTPUT
F:ETURN
FOR J=l TO L STEP 2
PRil'H"LINE #"; (J+1) /2; II: II;
SL=XY(J)/S2<J>
GOSUB 61 (l
F'F: I NT" F:EGF:ESS I ON THF:OUGH OF: I GIN : \( = " ~ SL; "·!ol- X 11
GOSUB 540:!F A$="Y" THEN GOSUB 4880
NEXT ,J
F:;:ETURN
PF: r NT" OBSEF:'-.JED xII :• "ossEF:VED Y", "CALCULATED v"
FOR I=l TO N<J>

PRINT DA<I,J>,DA<I,J+1),YC
NEXT I
GOSUB 570
GOSUB 590:IF X=999 THEN PRINT:RETURN
vc=SL*X: PRINT ::<, "", ·y·c
GOTO 4'=?40
F:ETUF:N
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5000 DATA

5~ "AI\If~LYSIS OF THE F:EGF:ESSION LINE"
5030 GOSUB 710:REM-INPUT
5040 GOSUB 5200:REM-OUTPUT
5050 GOSUB 5400:REM-PROCESS
5060 F:ETUF:N
5200 GOSUB 2200
5210 FOR J=1 TO L STEP 2:GOSUB 5220:NEXT J:RETURN
522C> GOSUB 3230
!523() XX=O:SS=O:R=O:EM=O:EB=O:EX=O
5240 FOF: I= 1 TO !\1
525C> X-DA (I, ,J)
5260 XX=XX+<X-XM)*(X-XM)
!5:27(> Y=DA (I~ J + 1 >
5280 CY=I'1* )( +8
~529(> SS=SS+((Y-CY>*<Y-CY))
5300 NEXT I
~531 (>

532(>
!533(>
534(>
5350
5360
5370
5380
5400
5410
5420
5430
5440
5460
5470
5490
~551 0
5550
5555
5560
~3600

5610
5620
5700
5720
~57 40
~5999

XX(J)=XX
R(J)=CXY-<N*XM*YM))/SQRC<X2-<N*<XM*XM> ))*(Y2-<N*<YM*YM))))
S=SQR<SS!<N-2>>:S<J>=S
EM<J>=S*SQR(1/XX)
EY<J>=S*SQR<Cl/N)+(XM*XM/XX>>
EXCJ)=ABS<SIM)*SQR((1/N)+(YM/M)*CYM/M)/XX>
F:ETURN
FOR J=1 TO L STEP 2:GOSUB 5410:NEXT J:GOSUB 3860:RETURN
GOSUB 3830
N=N ( J) -2: X I·$=" X-INTEF:CEPT 11
PF: I NT II COF:F:ELATI ON COEFF I c I Ei'.tT = II;; F: ( J)
PF: I NT: GOSUB 5600: T=TB ( N) : PF: I NT II ( ST AI\ID. EF:ROF:) II
p 1 ':$=II ~:3LOPE II : P2=M ( J) : P3=El"l ( J) * T: P4=El"l ( J) : GOSUB 5550
P 1 $= 11 Y-INTEF:CEPT 11 : P2=8 <J) : P3=EY <J) *T: P4=EY< J) : l30SUB 5550
P1$=XIS:P2=-8(J)/MCJ):P3=EX(J)*T:P4=EXCJ>:GOSUB 5550
F:ETURN
REM HOLD. POINT
PF:INT F'1 $;II = II; STR$ <P2) ~II +,/- II;; STF:$ (F'3);; II (II; STF:$ <P4); II)
F:ETUF:I'.t
GOSUB 2960
F'F:INT"T TABLE VALUE; = II; TV; TAB (29); "DF ="; 1\1; II p ·- 95i~" ~
F:ETUF:N·
GOSUB 5600: F'F:INT: F'RINT"T CALCULATED = II~ ,:4BS (T) ~
PF:H-.IT TAB (29);: IF ABS (T) <TV THEN PF:INT "NOT II;
F'F: I NT II sIGN IF I CAI'.IT"
F:ETUF:r-.1

II
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.;SOOO
6010
6020
6030
6040
6050
6060
.:S 1 (H)
611 0
6120
6800
6810
6820
6830
6840
6850
6860
6870
6999
40000
41000
42010
42020
4:2040
42050
4:21 (H)
50000
50030
~50040

50050
50060
50065
50070
50080
50090
50100

DATA 6~ "PAF:ALLEL LINES I: TEST FOF: PAF:ALLELISM"
F:EM
REM
SUBROUTINES: 2~3~5
GOSUB 6100:REM INPUT
GOSUB 5200:REM PROCESS
GOSUB 6800:REM OUTPUT
F:ETUF:N
GOSUB 71 0
IF L <4 THEN PF: I NT II YOU 1'1UST HAVE MOF:E THAN ONE L I i'.iE I II :
ID=O: GOTO .S100
F:ETUF:N
GOSUB 3050
FOR J=3 TO L STEP 2
T=O:SP=O
SP=SQR(((N(1)-2)*8(1)A2+(N(J)-2)*S(J)A2)/(N(1)+NCJ)-4))
T=ABS<CM<1>-MCJ))/CSP*SQRCC1/XXC1))+(1/XXCJ)))))
PF:INT: PF:INT"LINE # 1 \}S. LINE #"; (J-1-1) /2; II:"
N=NC1)+NCJ>-4:GOSUB 5700
NEXT J
F:ETUF:N
DATA O~"END"
REM
READ TABLE DATA
IF FI$=FL$ AND TBCN><>O THEN RETURN
PFUNT:PF:INT"ENTEF: ";FI$; "TABLE '·iALUE FOF:";i'H "D .. F.";
NL=N: FL$=FI$: IN$= 11 ":INPUT INS: TB CN) =VAL CIN'$)
PF: I NT
RETUF:N
PF: I NT: F:EJ'1
ERROR TRAP ROUTINES
PRINT TAB (5) *******EF:ROR - ";
IF EF:F:=l :l THEN PRINT"DIIJISIOI'.t BY ZEF:O~ CHECK DATA!":
F:ESUME 50090
IF ERR=5 THEN F·F:H.IT" ILLEGAL FUNCTION~ CHEC~::: DATA!":
F:ESUME 50090
IF ERF:=8 THEN PRINT"SUBF:OUTINE DOES NOT EXIST **·lf*" ~
F:ESUME 50090
IF EF:F:=7 THEN PRINT"OUT OF 1'1EMOR'i <F:E-DH1ENSHJN OR F:E-F:Ui\1) ": F:ESUME 50999
~-=·F:INT"ON LINE #";EF:L;".
TYPE #"~EF:F:;".
RESUME 50100
GO SUB :.!. :L 0
GOSUB 500:RUN

50999 1:::1'-.ID
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